메뉴 건너뛰기




Volumn 63, Issue 3, 2004, Pages 259-264

Sirolimus-eluting stents for the prevention of restenosis in a worst-case scenario of diffuse and recurrent in-stent restenosis

Author keywords

Drug eluting stent; In stent restenosis; Sirolimus

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; RAPAMYCIN;

EID: 8544222631     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.20180     Document Type: Article
Times cited : (17)

References (17)
  • 2
    • 0037321509 scopus 로고    scopus 로고
    • Outcome after treatment of coronary in-stent restenosis: Results from a systematic review using meta-analysis techniques
    • Radke PW, Kaiser A, Frost C, Sigwart U. Outcome after treatment of coronary in-stent restenosis: results from a systematic review using meta-analysis techniques. Eur Heart J 2003;24:266-273.
    • (2003) Eur Heart J , vol.24 , pp. 266-273
    • Radke, P.W.1    Kaiser, A.2    Frost, C.3    Sigwart, U.4
  • 17
    • 0036787729 scopus 로고    scopus 로고
    • 7-Hexanoyltaxol-eluting stent for prevention of neointimal growth: An intravascular ultrasound analysis from the study to compare restenosis rate between Quest and QuaDS-QP2 (SCORE)
    • Kataoka T, Grube E, Honda Y, Morino Y, Hur SH, Bonneau HN, Colombo A, Di Mario C, Guagliumi G, Hauptmann KE, et al. 7-hexanoyltaxol-eluting stent for prevention of neointimal growth: an intravascular ultrasound analysis from the study to compare restenosis rate between Quest and QuaDS-QP2 (SCORE). Circulation 2002;106:1788-1793.
    • (2002) Circulation , vol.106 , pp. 1788-1793
    • Kataoka, T.1    Grube, E.2    Honda, Y.3    Morino, Y.4    Hur, S.H.5    Bonneau, H.N.6    Colombo, A.7    Di Mario, C.8    Guagliumi, G.9    Hauptmann, K.E.10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.